Application of Non-inductive Intelligent Physical Sign Monitoring Equipment Based on Flexible Electronic Devices in the Diagnosis and Treatment of Cardiovascular Diseases
Condition(s) studied
Investigational drug(s) / intervention(s)
Non-invasive Smart Mattress Monitoring System: The investigational intervention is a mattress-form monitoring device embedded with flexible sensing fibers and a multi-parameter data acquisition system. It is placed atop a standard hospital bed to unobtrusively and continuously measure vital signs including heart rate, respiratory rate, body temperature, and body posture. The device transmits data wirelessly to a secure server for real-time display, storage, and analysis via dedicated software algorithms. In the initial validation phase (first 100 participants), its measurements are synchronously compared with those from conventional bedside monitors. In the subsequent primary monitoring phase, it functions as the sole continuous monitoring tool.
Study summary
This project is a single-center clinical evaluation study designed to validate a non-invasive mattress-based smart monitoring system. The system is intended for installation on standard hospital beds to provide continuous, contact-free monitoring of vital signs, including heart rate, respiration, body temperature, and posture, in patients with cardiovascular diseases. The system will integrate monitoring data with hospital information systems and personal health platforms to support clinical management and remote health monitoring.
Eligibility
Primary outcome measure(s)
- Heart Rate and Heart Rhythm — For three consecutive days, from 22:00 to 07:00 each day
Conventional vital signs monitoring devices or smart sensors embedded in mattresses for monitoring.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Beijing Anzhen Hospital, Capital Medical University | Beijing | China | Recruiting |
More Beijing Anzhen Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07466056 on ClinicalTrials.gov ↗ ← All trials in China